Literature DB >> 19870847

QUANTITATIVE RELATIONSHIPS BETWEEN THE IMMUNIZING DOSE OF EPIDEMIC INFLUENZA VIRUS AND THE RESULTANT IMMUNITY.

T Francis1.   

Abstract

A direct proportion exists between the concentration of epidemic influenza virus used for intraperitoneal immunization of mice and the degree of immunity to intranasal infection which develops. Mice vaccinated with virus of a given strength resist infection with virus of the same concentration but not more. An irreducible minimum exists since mice vaccinated with less than ten intranasal lethal doses do not develop sufficient immunity to overcome intranasal infection with virus of the same strength. The fact that there exists a limiting threshold for the degree of immunity which a certain strength of virus will induce indicates that the virus does not multiply after intraperitoneal inoculations. In ferrets a state of partial immunity is induced as a result of subcutaneous vaccination with active influenza virus. Vaccination with doses containing 100 or more intranasal infectious units is required for the production of circulating antibodies, protection of the animals from pulmonary involvement, and modification of the severity of the disease. On the other hand, intranasal inoculation with one infectious unit results in a firm, immediate immunity, although the duration of immunity may bear a relation to the severity of the original infection and consequently to the size of the infecting dose. Ferrets in a state of partial immunity resulting from subcutaneous vaccination, or from the waning of a firm immunity following infection, respond to intranasal inoculation of influenza virus with an accelerated production of neutralizing antibodies. The antibody titer under these conditions reaches a much higher level than occurs following a primary infection. Fully immune animals, however, show no further antibody response to a second inoculation.

Entities:  

Year:  1939        PMID: 19870847      PMCID: PMC2133739          DOI: 10.1084/jem.69.2.283

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  RESULTS OF IMMUNIZATION BY MEANS OF ACTIVE VIRUS OF HUMAN INFLUENZA.

Authors:  J Stokes; A D Chenoweth; A D Waltz; R G Gladen; D Shaw
Journal:  J Clin Invest       Date:  1937-03       Impact factor: 14.808

2.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

3.  Etiological and Serological Studies in Epidemic Influenza.

Authors:  T Francis; T P Magill; E R Rickard; M D Beck
Journal:  Am J Public Health Nations Health       Date:  1937-11

4.  IMMUNIZATION EXPERIMENTS WITH SWINE INFLUENZA VIRUS.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1936-06-30       Impact factor: 14.307

5.  ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : II. IMMUNIZATION WITH FORMOLIZED VIRUS.

Authors:  H R Cox; P K Olitsky
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

6.  ACTIVE IMMUNICATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : I. QUANTITATIVE EXPERIMENTS WITH VARIOUS PREPARATIONS OF ACTIVE VIRUS.

Authors:  P K Olitsky; H R Cox
Journal:  J Exp Med       Date:  1936-02-29       Impact factor: 14.307

7.  THE DEMONSTRATION OF LESIONS AND VIRUS IN THE LUNGS OF MICE RECEIVING LARGE INTRA-PERITONEAL INOCULATIONS OF EPIDEMIC INFLUENZA VIRUS.

Authors:  E R Rickard; T Francis
Journal:  J Exp Med       Date:  1938-05-31       Impact factor: 14.307

8.  THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

9.  ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : III. QUANTITATIVE STUDIES OF SERUM ANTIVIRAL BODIES IN ANIMALS IMMUNIZED WITH ACTIVE AND INACTIVE VIRUS.

Authors:  H R Cox; P K Olitsky
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

  9 in total
  12 in total

1.  Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72.

Authors:  F A Ennis; M A Wells; D W Barry; S Daniel; J Manischewitz
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

2.  Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines.

Authors:  C W Potter; R Jennings; C McLaren
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Vaccination against influenza.

Authors:  T FRANCIS
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

4.  THE SYNERGISM OF HUMAN INFLUENZA AND CANINE DISTEMPER VIRUSES IN FERRETS.

Authors:  F L Horsfall; E H Lennette
Journal:  J Exp Med       Date:  1940-08-31       Impact factor: 14.307

5.  Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.

Authors:  A Cristina Paulo; Margarida Correia-Neves; Tiago Domingos; Alberto G Murta; Jorge Pedrosa
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

6.  Observations with the electron microscope on cells of the chick chorio-allantoic membrane infected with influenza virus.

Authors:  J S MURPHY; F B BANG
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

7.  THE INACTIVATION OF THE VIRUS OF EPIDEMIC INFLUENZA BY SOAPS.

Authors:  C C Stock; T Francis
Journal:  J Exp Med       Date:  1940-04-30       Impact factor: 14.307

8.  Formation of non-infectious influenza virus in mouse lungs: its dependence upon extensive pulmonary consolidation initiated by the viral inoculum.

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307

9.  THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION.

Authors:  J E Salk; G I Lavin; T Francis
Journal:  J Exp Med       Date:  1940-11-30       Impact factor: 14.307

10.  THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION.

Authors:  W M Stanley
Journal:  J Exp Med       Date:  1945-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.